Fig. 5
From: DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms
Tissue expression of DCYTB and DMT1. Representative images of immunohistochemical staining of a breast tissue microarray (×20 magnification) and de-identified duodenal tissue from UConn Health Center Department of Pathology. a, d Normal adjacent breast tissue; b, e cribriform-type DCIS ER/PR+; c, f invasive ductal carcinoma, grade 3, triple negative; g, h normal human duodenum, ×40; i normal adjacent breast tissue, control stained with secondary antibody only, ×40; j normal human duodenum, control stained with IgG instead of primary antibody, ×40. The box in the series of images to the left, a-c and d-f, represent the location of the magnified image to the right. Scale bar = 20 μm. DCIS ductal carcinoma in situ, DCYTB duodenal cytochrome b, DMT1 divalent metal transporter 1, ER estrogen receptor, PR progesterone receptor